Showing results (721-730 of 982) with videos related to
Sort By:
Pageof 99
Cardiovascular Therapeutics|May 11, 2026
Association Between HALP Score and Atrial Fibrillation Recurrence After Radiofrequency Catheter AblationQing Yan, Yide Yuan, Yuyang Zhao, et al.Cardiovascular Therapeutics|April 26, 2026
Integrating Traditional Wisdom With Modern Science: Ginsenosides as Antiheart Failure AgentsLi Zhou, Yanhua Li, Wenjie Yin, et al.Cardiovascular Therapeutics|May 24, 2011
Influence of sex on treatment and outcome in chronic heart failureLutz Frankenstein, Andrew L Clark, Jorge P RibeiroCardiovascular Therapeutics|May 27, 2026
Combination Therapy With Beta-Blockers and Angiotensin-Converting Enzyme Inhibitors for Cardiovascular Diseases: Focus on Bisoprolol/RamiprilAgostino VirdisCardiovascular Therapeutics|March 20, 2020
Effects of Angiotensin-Converting Enzyme Inhibitors on Arterial Stiffness: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsXiuli Li, Peng Chang, Qiongying Wang, et al.Cardiovascular Therapeutics|June 16, 2026
Lycorine Attenuates Cardiac Fibrosis Through the Regulation of PYK2 Expression and ActivityXiuxiu Gao, Ying Zhang, Dongzhe Li, et al.Cardiovascular Therapeutics|June 29, 2026
Integrated Network Pharmacology and Experimental Validation Approach to Systematically Elucidate the Cardioprotective Mechanisms of Shengmai InjectionNan Hu, Hongnv Zhang, Zhenghao Wang, et al.Cardiovascular Therapeutics|July 17, 2026
Magnetocardiography for Exploratory Risk Stratification in Patients With Three-Vessel Coronary Artery Disease: A Single-Center Prospective Cohort StudyZiyu An, Shipan Wang, Min Zhang, et al.Cardiovascular Therapeutics|August 18, 2026
Prodrug Strategies in Atherosclerosis: Targeted Delivery and Therapeutic AdvancesElaheh Mirhadi, Wael Almahmeed, Prashant Kesharwani, et al.Cardiovascular Therapeutics|December 3, 2021
CTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in RatsHua Guan, Xiaofeng Yang, Tao Shi, et al.Pageof 99